{
  "guid": "http://files.libertyfund.org/econtalk/y2017/Feldmandrugs.mp3",
  "title": "Robin Feldman on Drug Patents, Generics, and Drug Wars",
  "description": "<p>Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.</p>\n",
  "pubDate": "Mon, 26 Jun 2017 06:30:00 +0000",
  "author": "webmaster@econlib.org (EconTalk: Russ Roberts)",
  "link": "https://www.econtalk.org/robin-feldman-on-drug-patents-generics-and-drug-wars/",
  "content:encoded": "<p>Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.</p>\n",
  "enclosure": "",
  "itunes:title": "Robin Feldman on Drug Patents, Generics, and Drug Wars",
  "itunes:author": "EconTalk: Russ Roberts",
  "itunes:duration": "01:05:22",
  "itunes:summary": "Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.",
  "itunes:subtitle": "Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.",
  "itunes:keywords": "economics, intellectual property, competition, pharmaceuticals, robin feldman, antitrust, econlib, fda",
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "itunes:episode": 583
}